Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 1949919)

Published in Mol Med on October 01, 2000

Authors

Y G Kim1, X R Huang, S Suga, M Mazzali, D Tang, C Metz, R Bucala, S Kivlighn, R J Johnson, H Y Lan

Author Affiliations

1: Division of Nephrology, University of Washington Medical Center, Seattle, USA.

Articles by these authors

Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol (2001) 7.40

Action of nicking-closing enzyme on supercoiled and nonsupercoiled closed circular DNA: formation of a Boltzmann distribution of topological isomers. Proc Natl Acad Sci U S A (1975) 6.26

The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ (2011) 5.95

MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 5.60

The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med (1994) 5.55

MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 5.21

Noncontact anterior cruciate ligament injuries: risk factors and prevention strategies. J Am Acad Orthop Surg (2000) 4.61

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41

Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med (2000) 3.89

An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest (1994) 3.70

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest (1991) 3.70

Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA) Lancet (1999) 3.67

Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry (1994) 3.58

A statistical paradigm for neural spike train decoding applied to position prediction from ensemble firing patterns of rat hippocampal place cells. J Neurosci (1998) 3.20

Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol (1998) 3.09

Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int (1999) 3.09

Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem (1992) 3.06

Effect of corneal polarization axis on assessment of retinal nerve fiber layer thickness by scanning laser polarimetry. Am J Ophthalmol (2000) 3.01

Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med (1997) 2.98

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia (2010) 2.83

Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73

Local hyperthermia in combination with definitive radiotherapy: increased tumor clearance, reduced recurrence rate in extended follow-up. Int J Radiat Oncol Biol Phys (1984) 2.72

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature (1996) 2.71

Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics (1993) 2.67

In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob Agents Chemother (1996) 2.63

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J (1998) 2.62

Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem (1999) 2.60

Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology (1994) 2.55

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A (1997) 2.53

Negative regulation of defense responses in plants by a conserved MAPKK kinase. Proc Natl Acad Sci U S A (2001) 2.51

Factors effecting late results after meniscectomy. J Bone Joint Surg Am (1974) 2.49

Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension (1999) 2.44

Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) (2009) 2.39

The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36

Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ (2009) 2.30

The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci U S A (2003) 2.29

A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun (2002) 2.21

The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med (1996) 2.21

The use of health services by older adults. J Gerontol (1991) 2.18

Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17

Simultaneous occurrence of human herpesvirus 6 infection and intussusception in three infants. Pediatr Infect Dis J (1991) 2.16

Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest (1995) 2.15

Prospective study of follow up alone in stage I teratoma of the testis. Br Med J (Clin Res Ed) (1983) 2.13

Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology (2005) 2.13

Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol (1999) 2.11

An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med (1999) 2.10

Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A (1997) 2.10

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A (1992) 2.09

Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.09

Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene (2007) 2.08

Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02

Mechanical changes in the knee after meniscectomy. J Bone Joint Surg Am (1976) 2.00

Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00

An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med (1996) 1.99

Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98

Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1997) 1.95

Strain within the anterior cruciate ligament during hamstring and quadriceps activity. Am J Sports Med (1986) 1.95

Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1996) 1.95

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation (2000) 1.93

Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J (2001) 1.91

Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest (1994) 1.91

Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90

Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun (1998) 1.87

Trends in skiing injuries. Analysis of a 6-year study (1972 to 1978). Am J Sports Med (1980) 1.86

Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol (1997) 1.86

The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med (1997) 1.86

The risk of nursing home placement and subsequent death among older adults. J Gerontol (1992) 1.86

Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest (1998) 1.85

Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol (1998) 1.83

Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83

A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology (2005) 1.81

[Red free light magnifying photography in neuritis and some retinal vascular lesions]. Nihon Ganka Kiyo (1969) 1.81

Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A (2005) 1.79

De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res (2000) 1.78

Epidemiological studies of leukaemia in children and young adults around nuclear facilities: a critical review. Radiat Prot Dosimetry (2008) 1.77

A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant (2006) 1.75

New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75

Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int (2001) 1.75

An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci U S A (1999) 1.74

The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol (1988) 1.73

Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst (1994) 1.72

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72

Changes in functional status and the risks of subsequent nursing home placement and death. J Gerontol (1993) 1.71